Table 5.
Serum ceruloplasmin, copper oxidase, and copper in WD patients.
Generally | Men (mean and SD) | Women (mean and SD) | P-value |
---|---|---|---|
Neuropsychiatric form | |||
Ceruloplasmin in μg/ml | 72.28 ± 46.56 | 66.93 ± 36.58 | 0.172 |
Serum copper level in μmol/l | 3.73 ± 2.54 | 3.54 ± 2.06 | 0.378 |
Hepatic form | |||
Ceruloplasmin in μg/ml | 60.98 ± 26.11 | 55.85 ± 27.88 | 0.438 |
Serum copper level in μmol/l | 3.48 ± 1.81 | 3.92 ± 2.03 | 0.344 |
Presymptomatic form | |||
Ceruloplasmin in μg/ml | 57.59 ± 23.40 | 67.55 ± 41.01 | 0.570 |
Serum copper level in μmol/l | 3.29 ± 1.83 | 3.20 ± 1.69 | 0.930 |
P for significance after Bonferroni correction: 0.006.